Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study

BACKGROUND/AIMS: This study compared the efficacy of once-daily administration of multimatrix mesalazine 2.4 g/day with multiple-dose mesalazine for the maintenance of remission. METHODS: In this multicenter, randomized, double-blind study, 203 patients with ulcerative colitis in remission received...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Intest Res
Главные авторы: Ogata, Haruhiko, Ohori, Akihiro, Nishino, Haruo, Mizushima, Seiichi, Hagino, Atsushi, Hibi, Toshifumi
Формат: Artigo
Язык:Inglês
Опубликовано: Korean Association for the Study of Intestinal Diseases 2017
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5478761/
https://ncbi.nlm.nih.gov/pubmed/28670233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5217/ir.2017.15.3.358
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы